Correlation Between Arcus Biosciences and Dominari Holdings
Can any of the company-specific risk be diversified away by investing in both Arcus Biosciences and Dominari Holdings at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Arcus Biosciences and Dominari Holdings into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Arcus Biosciences and Dominari Holdings, you can compare the effects of market volatilities on Arcus Biosciences and Dominari Holdings and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Arcus Biosciences with a short position of Dominari Holdings. Check out your portfolio center. Please also check ongoing floating volatility patterns of Arcus Biosciences and Dominari Holdings.
Diversification Opportunities for Arcus Biosciences and Dominari Holdings
0.32 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Arcus and Dominari is 0.32. Overlapping area represents the amount of risk that can be diversified away by holding Arcus Biosciences and Dominari Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dominari Holdings and Arcus Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Arcus Biosciences are associated (or correlated) with Dominari Holdings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dominari Holdings has no effect on the direction of Arcus Biosciences i.e., Arcus Biosciences and Dominari Holdings go up and down completely randomly.
Pair Corralation between Arcus Biosciences and Dominari Holdings
Given the investment horizon of 90 days Arcus Biosciences is expected to generate 1.05 times more return on investment than Dominari Holdings. However, Arcus Biosciences is 1.05 times more volatile than Dominari Holdings. It trades about 0.01 of its potential returns per unit of risk. Dominari Holdings is currently generating about -0.04 per unit of risk. If you would invest 1,858 in Arcus Biosciences on September 26, 2024 and sell it today you would lose (267.00) from holding Arcus Biosciences or give up 14.37% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Arcus Biosciences vs. Dominari Holdings
Performance |
Timeline |
Arcus Biosciences |
Dominari Holdings |
Arcus Biosciences and Dominari Holdings Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Arcus Biosciences and Dominari Holdings
The main advantage of trading using opposite Arcus Biosciences and Dominari Holdings positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Arcus Biosciences position performs unexpectedly, Dominari Holdings can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dominari Holdings will offset losses from the drop in Dominari Holdings' long position.Arcus Biosciences vs. Cullinan Oncology LLC | Arcus Biosciences vs. Annexon | Arcus Biosciences vs. Structure Therapeutics American | Arcus Biosciences vs. Relay Therapeutics |
Dominari Holdings vs. Fate Therapeutics | Dominari Holdings vs. Caribou Biosciences | Dominari Holdings vs. Karyopharm Therapeutics | Dominari Holdings vs. Hookipa Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Global Correlations Find global opportunities by holding instruments from different markets |